바이오테크 보도자료
-
- Vifor Pharma to propose Åsa Riisberg for appointment to Board of Directors
- Regulatory News: Vifor Pharma is pleased to announce that the Board of Directors will propose Åsa Riisberg for election to the Board at the Annual General Meeting on 6 May 2021. Åsa Riisberg, a Swedish citizen, was formerly Partner and member of t...
- 2021년 03월 29일
-
- AOP Orphan reports full validity of arbitral award against PharmaEssentia
- Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP Orphan concerning BESREMi® (Ropeginterferon alfa-2b). After two and a half years of arbitral proceedings, in October 2020, the ICC Arbitral Tribunal issued its...
- 2021년 03월 26일
-
- Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency (EMA) has accepted the Company’s filing packages for its dengue vaccine candidate (TAK-003) which is being investigated for the...
- 2021년 03월 26일
-
- Alvotech Disputes AbbVie’s Recent Allegations
- Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will vigorously defend against these allegations. Notably, AbbVie waited over three years from the pu...
- 2021년 03월 26일
-
- Philip Morris International Announces the Nomination of International Executives to Its Board of Directors
- Philip Morris International Inc. (PMI) (NYSE: PM) announced in the 2021 Proxy Statement filed today that its Board of Directors has nominated two new members, Dr. Juan José Daboub and Mr. Shlomo Yanai. Additionally, Mr. Jacek Olczak has been nomin...
- 2021년 03월 26일
-
- Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
- Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are available. In particular, efforts to research potential COVID-19 re...
- 2021년 03월 24일
-
- Yokogawa Establishes Yokogawa Bio Frontier Inc. to Advance Biomass Materials Business
- Yokogawa Electric Corporation (TOKYO:6841) announces the launch of Yokogawa Bio Frontier Inc. to develop businesses related to the production and sales of innovative plant-derived biomass materials, as well as associated licensing and consulting a...
- 2021년 03월 22일
-
- Humanigen Sets Date for Virtual Annual Shareholders Meeting
- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, announced today that its board ...
- 2021년 03월 22일
-
- Humanigen Expands its anti-GM-CSF Patent Portfolio
- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, today announced the company has ...
- 2021년 03월 18일
-
- New syringe barrel size reduces the number of assembly fluid changeovers required for automated manufacturing processes
- Nordson EFD, a Nordson company (NASDAQ: NDSN) and a leading precision fluid dispensing systems manufacturer, introduces the largest sized syringe barrel in its Optimum dispensing components line. The 70cc syringe barrel holds more assembly fluids,...
- 2021년 03월 17일
-
- Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions
- XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges, is pleased to announce today the five winning teams in the $6M XPRIZE Rapid Covid Testing competition, with each winner creating hig...
- 2021년 03월 17일
-
- PCI Pharma Broadens Clinical Trial Service Offerings at Berlin Facility, Bringing Worldwide Access to Clients in the European Union
- PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced a new milestone in its global Clinical footprint with the expansion of cold chain clinical supply storage and distribu...
- 2021년 03월 17일
-
- Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Take...
- 2021년 03월 16일
전시회
